借力推动前列腺癌 CAR-T 细胞治疗进展
Piggybacking toward Progress for CAR T-Cell Therapy in Prostate Cancer.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Immune mechanisms behind prostate cancer in men of African ancestry: A review.
Immune mechanisms behind prostate cancer in men of African ancestry: A review.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
AA 前列腺癌患者可能富集免疫原性表型。
非洲血统(AA)男性前列腺癌患者结局较差。但近期一项评估前列腺癌患者接受树突状细胞疫苗西普鲁塞-T治疗的分析提示,AA患者的结局可能优于白人患者。
重点回顾Medline收录的文章和ClinicalTrials.gov登记的临床试验。
多项研究提示,AA前列腺癌患者的炎症性细胞浸润及细胞因子信号通路富集。本文概述可能促成免疫原性的基因组和转录组变化,并探讨AA患者宿主免疫和疫苗应答可能增强的差异。
AA前列腺癌患者可能更富集免疫原性表型。仍需开展专门研究,更好理解造成现有癌症差异的免疫机制,并在这一人群中检验免疫疗法。
Men of African ancestry (AA) with prostate cancer suffer from worse outcomes. However, a recent analysis of patients treated with the dendritic cell vaccine sipuleucel-T for prostate cancer suggested that AA patients could have improved outcomes relative to whites.
We conducted a focused literature review of Medline-indexed articles and clinical trials listed on clinicaltrials.gov.
We identify several studies pointing to enrichment of inflammatory cellular infiltrates and cytokine signaling among AA patients with prostate cancer. We outline potential genomic and transcriptomic alterations that may contribute to immunogenicity. Last, we investigate differences in host immunity and vaccine responsiveness that may be enhanced in AA patients.
AA patients with prostate cancer may be enriched for an immunogenic phenotype. Dedicated studies are needed to better understand the immune mechanisms that contribute to existing cancer disparities and test immune-based therapies in this population.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。